November 2, 2026

ONSITE: Model Informed Bioequivalence (MIBE) using Pumas

Date: November 2, 2026, 8:30 – 17:30

Location: Santiago de Chile, Chile

Instructors: Mike Tagen, PhD and Lucas Pereira

Register Now!

Overview

Traditional non-compartmental bioequivalence (BE) analysis struggles with complex scenarios like long-acting formulations or high variability due to intensive sampling demands. This workshop introduces model-based BE using population non-linear mixed-effects (NLME) modeling and simulation to handle sparse data, increase statistical power, and optimize trial designs.

Hands-on exercises in Pumas guide participants through a complete workflow: model setup, clinical trial simulation, BE assessment, and power and Type I error analysis. Real-world case studies cover long-acting injectables, baseline-corrected levothyroxine, narrow therapeutic index drugs, EMA reference-scaled BE, and pediatric extrapolation.

The workshop closes with validation methodology, including virtual cohorts and flexible sampling schedules. Attendees leave with reusable, executable Pumas code to apply these advanced techniques directly to their own trials.

Follow these steps for a seamless registration experience:

  1. Visit https://kongreso.com/.
  2. Scroll down to RedIF 2026: VI Congress of the Ibero-American Pharmacometrics Network.
  3. From the left-hand panel, select Activities. Locate the workshop, which is listed as the second item in this section.
  4. Press Enter to complete your registration.

twitter

In other Events...

WEBINAR
Model-Informed Early Go/No-Go in Oncology

In other Events...

CONFERENCE
The VI RedIF Congress

Leading businesses, research labs and universities choose us as their healthcare intelligence partners.

PumasAI News and Events
PumasAI.svg
Pumas-AI Inc.
3500 South Dupont Highway
Suite GT-101
Dover, DE 19901
Email: info@pumas.ai
twittertwitter
Pumas-AI Inc.
3500 South Dupont Highway
Suite GT-101
Dover, DE 19901
Email: info@pumas.ai
twittertwitter

© Pumas-AI Inc. 2026. All rights reserved.